Feedback / Questions
64/67Cu SAR-bisPSMA theranostic - Clarity Pharma
https://www.prnewswire.com/news-releases/ind-approval-from-the-us-fda-for-theranostic-sar-bombesin-trial-in-prostate-cancer-301683510.html
Nov 21, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next